#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic granulomatous disease Synovial sarcoma recurrent Dupuytren's contracture Hypoparathyroidism Neonatal asphyxia Glomerulonephritis membranous Splenic marginal zone lymphoma Hereditary neuropathic amyloidosis Crohn's disease Restless legs syndrome Testicular leiomyosarcoma Neoplasm malignant Myxofibrosarcoma Choroid melanoma Chronic cutaneous lupus erythematosus More trials…

    Learn about Rare Diseases

    Langerhans’ cell histiocytosis Brain stem glioma – Treatment Hereditary ataxia Mast cell activation syndrome – Diagnostics Ocular melanoma – Diagnostics Acquired haemophilia – Trials in Disease Vascular malformation – Treatment Optic glioma – Trials in Disease Leiomyosarcoma recurrent – Life with Disease Chondrosarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nirmatrelvir Rtp-026 Sodium Mcla-129 Polydextrose Mva-Hbvac Atezolizumab Bms-986442 Tilmanocept Etamsylate Mifepristone Foscarnet Sodium Hexahydrate Transpocart19 Pivmecillinam Hydrochloride Gemcitabine Human Coagulation Factor Ix Ly3473329 Caffeine Citrate Gentamicin Dapagliflozin Ezabenlimab More therapies…

    Learn about Your Condition

    Stress urinary incontinence Exposure via breast milk Pemphigoid Milk allergy Testicular leiomyosarcoma Inclusion body myositis Testicular germ cell cancer Glaucoma Hepatorenal syndrome Salivary gland cancer Cardiac ventricular thrombosis Intracranial aneurysm Limb reduction defect Bladder cancer Exfoliation glaucoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study of Zr89-trastuzumab PET/CT imaging and trastuzumab emtansine treatment in patients with advanced HER2-positive breast cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    • HER2 positive breast cancer
    Investigated Drugs:
    • Trastuzumab Emtansine
    • Trastuzumab
    Belgium

  • Study on Bupropion Hydrochloride and Naltrexone Hydrochloride for Patients with Weight Regain After Bariatric Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metabolic surgery
    • Obesity
    Investigated Drugs:
    • Naltrexone Hydrochloride
    • Bupropion Hydrochloride
    The Netherlands

  • Study on the Effectiveness of Autologous Bone Marrow-Derived Mononuclear Cells and Angioplasty in Diabetic Patients with Chronic Limb-Threatening Ischemia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic foot
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • AUTOLOGOUS BONE MARROW-DERIVED MONONUCLEAR CELLS
    Czechia

  • Study on Carotid Stenosis: Evaluating Evolocumab for Plaque Stabilization and Regression in Patients with Carotid Artery Narrowing

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Carotid artery stenosis
    Investigated Drugs:
    • Evolocumab
    Italy

  • Study Comparing Teriparatide and Alendronate for Preventing Bone Fractures in Women Over 65 with Fragile Bones

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • ALENDRONATE SODIUM TRIHYDRATE
    • Teriparatide
    Spain

  • Study on Pain Relief After Wisdom Tooth Surgery Using Etoricoxib and Celecoxib for Patients Undergoing Mandibular M3 Removal

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Etoricoxib
    • Celecoxib
    Hungary
Previous Page
1 … 834 835 836 837 838 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!